Summary:
Atc Group V03Ab* Medicinal Products* Country:
Czech Republic Estimated Cost:
EUR 12530000 Notice Type:
Tender Notice Deadline:
07 Jul 2025 Posting Date:
03 Jun 2025 |
Summary:
Delivery Lp - Biologics Ix. Country:
Czech Republic Estimated Cost:
EUR 604643000 Notice Type:
Tender Notice Deadline:
02 Jul 2025 Posting Date:
03 Jun 2025 |
Summary:
Lp Containing Ondasetron 2025 Country:
Czech Republic Estimated Cost:
EUR 2259978 Notice Type:
Tender Notice Deadline:
04 Jul 2025 Posting Date:
03 Jun 2025 |
Summary:
Amino Acids 2025 Country:
Czech Republic Estimated Cost:
EUR 5626839 Notice Type:
Tender Notice Deadline:
04 Jul 2025 Posting Date:
02 Jun 2025 |
Summary:
Drugs - Humira 2025 Country:
Czech Republic Estimated Cost:
EUR 92524000 Notice Type:
Tender Notice Deadline:
30 Jun 2025 Posting Date:
02 Jun 2025 |
Summary:
Lp Containing Adalimumab 2025 Country:
Czech Republic Estimated Cost:
EUR 7780228 Notice Type:
Tender Notice Deadline:
03 Jul 2025 Posting Date:
02 Jun 2025 |
Summary:
Drug Supply - The Active Substance Rivaroxaban - Atc B01Af01 Country:
Czech Republic Estimated Cost:
EUR 12839137 Notice Type:
Tender Notice Deadline:
30 Jun 2025 Posting Date:
02 Jun 2025 |
Summary:
Dynamic Purchase System: Health And Non -Medical Szm Country:
Czech Republic Estimated Cost:
EUR 300000000 Notice Type:
Tender Notice Deadline:
17 Jun 2025 Posting Date:
02 Jun 2025 |
Summary:
Un Motol - Tilldrakizumab 200 Mg Country:
Czech Republic Estimated Cost:
EUR 16207818 Notice Type:
Tender Notice Deadline:
11 Jun 2025 Posting Date:
02 Jun 2025 |
Summary:
Antibacterial Substances For Systemic Use Xxxvi. - Betalactam Atb Country:
Czech Republic Estimated Cost:
EUR 10418000 Notice Type:
Tender Notice Deadline:
30 Jun 2025 Posting Date:
30 May 2025 |